DeepMed Research

National Heart, Lung, and Blood Institute

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

Recruiting

Conditions: Cardiomyopathy
Li-Fraumeni Syndrome
Parkinson's Disease
Atherosclerosis
Cardiovascular Capacity

First Posted Date: 2010-06-14

Last Posted Date: 2025-05-06

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 5000

Registration Number: NCT01143454

Locations: 🇺🇸
Suburban Hospital, Bethesda, Maryland, United States
🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Evaluation of Oral Alpha-Cyclodextrin for Decreasing Serum Cholesterol

Phase 2

Completed

Conditions: Cardiovascular Disease

Interventions: Other: Placebo
Drug: Alpha cyclodextrin

First Posted Date: 2010-05-26

Last Posted Date: 2016-10-21

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 103

Registration Number: NCT01131299

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

A Study of the Kinetics of Lymphoid Cells in Patients With Monoclonal B-cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma (MCL) and Healthy Volunteers

Completed

Conditions: Lymphoma, Mantle-cell
Monoclonal B-Cell Lymphocytosis
CLL (Chronic Lymphocytic Leukemia)
Healthy Volunteers
Small Lymphocytic Lymphoma

First Posted Date: 2010-05-05

Last Posted Date: 2020-07-14

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 20

Registration Number: NCT01117142

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)

Phase 3

Completed

Conditions: Multiple Myeloma

Interventions: Drug: lenalidomide, bortezomib and dexamethasone
Drug: Lenalidomide

First Posted Date: 2010-04-22

Last Posted Date: 2021-12-09

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 758

Registration Number: NCT01109004

Locations: 🇺🇸
Georgia Health Sciences University, Augusta, Georgia, United States
🇺🇸
University of Kentucky, Lexington, Kentucky, United States
🇺🇸
UCSD Medical Center, La Jolla, California, United States

and more 51 locations

Gardasil Vaccination in Post Stem Cell Transplant Patients

Phase 1

Completed

Conditions: Immunogenicity
Gardasil Vaccine
Stem Cell Transplant

Interventions: Biological: Gardasil

First Posted Date: 2010-03-24

Last Posted Date: 2019-08-06

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 64

Registration Number: NCT01092195

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Fish Oil In Heart Transplantation

Not Applicable

Conditions: Myocardial Tissue in Heart Transplantation

First Posted Date: 2010-02-22

Last Posted Date: 2016-07-29

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 50

Registration Number: NCT01072994

New Techniques to Evaluate Mitral Regurgitation

Completed

Conditions: Mitral Valve Regurgitation

First Posted Date: 2010-02-05

Last Posted Date: 2019-12-17

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 50

Registration Number: NCT01063322

Locations: 🇺🇸
Suburban Hospital, Bethesda, Maryland, United States
🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Cardiac MRI for Patients Enrolled in INFUSE-AMI

Completed

Conditions: Myocardial Fibrosis
Coronary Artery Disease
Acute Myocardial Infarction
Myocardial Edema
Gadolinium

First Posted Date: 2010-01-29

Last Posted Date: 2019-09-13

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 455

Registration Number: NCT01059214

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Novel Influenza A (H1N1) Surveillance Registry

Completed

Conditions: Novel Influenza A
H1N1
Influenza

First Posted Date: 2010-01-12

Last Posted Date: 2016-04-14

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 894

Registration Number: NCT01046331

Locations: 🇺🇸
Children's Hospital and Research Center Oakland, Oakland, California, United States
🇺🇸
Children's Memorial Hospital, Chicago, Illinois, United States
🇺🇸
University of Colorado Health Sciences Center, Denver, Colorado, United States

and more 83 locations

Characterization of the Innate Immune Response in Healthy NIH Employees at Baseline and After Immunization With the H1N1 Vaccine

Completed

Conditions: Healthy Volunteers

First Posted Date: 2009-10-15

Last Posted Date: 2017-10-06

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 26

Registration Number: NCT00995527

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy